Laronde Alternatives & Competitors
12 companies similar to Laronde — Pioneering a completely novel translatable RNA platform - Endless RNA (eRNA)
Companies similar to Laronde
Alltrna
The world’s first transfer RNA (tRNA) platform company. We are unlocking the vast therapeu...
Cambridge, United States
Granza Bio
Reprogramming Immunity for Target-Specific Medicines
ReNAgade Therapeutics
RNA Without Limits
Cambridge, United States
Rival Readout
Competing with Laronde? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Ascidian Therapeutics
Rewriting RNA
Boston, United States
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
Cambridge, United States
Carbon Biosciences
Expanding Therapeutic Potential with Novel Parvovirus Gene Therapy
Boston, United States
Rgenta Therapeutics Inc.
We unlock the therapeutic potentials of highly disease-relevant targets undruggable by sma...
Woburn, United States
Avidity Biosciences, Inc.
At Avidity, we are developing a new class of oligonucleotide-based therapies.
San Diego, United States
Orna Therapeutics
Wholly Owned Subsidiary of Eli Lilly and Company
Watertown, United States
Differentiated Therapeutics Inc
What if you could predict molecules to make the cause of disease disappear?
San Diego, United States
Nephrogen
Curative gene therapies for kidney diseases
New York, United States
About Laronde
Laronde, founded in 2017 by Flagship Labs, is at the forefront of biotechnology innovation with its pioneering Endless RNA™ (eRNA) platform. Differentiated by its ability to modulate human biology, this uniquely engineered RNA can be programmed to express a variety of proteins within the body. Its persistent and non-im...
Development of programmable RNA medicines, Research and development of eRNA technology, Programmable nanoparticle deployment, Integrative AI-powered medicine design
Pharmaceutical companies, Healthcare providers, Biotechnology researchers, Patients with autoimmune, metabolic, infectious, and rare diseases
RNA Platform, Therapeutic Development, Innovation, Genetic Engineering, Flagship Pioneering, Flagship Labs, Biomedical Technology, Disease Treatment, Protein Expression, Drug Delivery, Persistent Therapy, Immunogenicity, Precision Medicine, Startup Investment
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Laronde: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Laronde on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
